SulNOx Group Plc
Since inception in 2013, the SulNOx Group has developed patent pending proprietary technology that now applies to over 70% of every barrel of oil. The market size for the company's products is now over 11 billion litres of petrol, diesel & heavy fuel oil each and every day.
SulNOx aims to become “the energy transition environmental stock” that immediately delivers on the aspirations of global corporations and politicians to move to “net zero emissions by 2050”. The SulNOxEco™ Fuel Conditioner is proven and already delivering value for our clients
- SulNOx technologies’ unique mechanism of action through oxygenation and emulsification of hydrocarbon fuels result in significant prevention of emissions (COx, NOx, SOx and Particulate Matter) before they are created.
- Our conditioners are simply poured into fuel tanks in low volumes and significantly reduce fuel and maintenance costs by improving combustion and lubricity.
- SulNOx not only scavenges to deal with the problem of ubiquitous free-water in fuel (universally viewed as a problematic and costly contaminant), but it also uses any free-water to an advantage by emulsifying it with the fuel.
- The addition of SulnoxEco™ Fuel Conditioners has been certified by the world renowned Bureau Veritas, not to take either diesel or petrol out of their regulatory bands.
- Any diesel or petrol engine in the world can therefore use The SulNOxEco™ Fuel Conditioner, without affecting engine warranties.
- SulNOx delivers long-term stability meaning fuel emulsions can be premixed and stored in tanks and bunkers.
- All the SulNOx products are made under licence by Nouryon, a multinational speciality chemical company with ability to produce bulk quantities globally with short lead times.
The adoption of SulNOx’s technology can make a real contribution to air quality, the climate change debate and save users money at the same time.
| Symbol | Ccy Code | Bid | Ask | Share Price (Mid) | Previous Close | Volume | Last Traded |
|---|---|---|---|---|---|---|---|
| SNOX | GBX | 15 | 16 | 15.5 | 15.5 | 20000 | 21.09.22 |
MiFID II compliant pre- and post-trade transaction data is available here. The data is delayed by at least 15 minutes and will be refreshed every 15 minutes. Publication of trades in equity securities that are large in scale compared to normal market size and illiquid non-equity securities may be delayed if the trade is eligible for deferred publication in accordance with the trading rules of Aquis Stock Exchange and MiFIR. Further details as to when the publication of a trade may be deferred are set out in the trading rules which are available here.
Financial Information
Performance
Earnings per share of -0.96p for 03/2021 has declined from -0.66p in 03/2019 or 45% over the period. Looking at this trend over the last 3 reported periods earnings are showing a decline.
Earnings per share
% growth (1)
03/2020 231% 03/2021 -56% Average over 3 periods+ 21%
LowHigh
(1) % growth is year on year % change in EPS.
Basic earnings per share are earnings from continuing and discontinued operations that are attributable to current equity holders.
Earnings per share of -0.96p for 03/2021 has declined from -0.66p in 03/2019 or 45% over the period. Looking at this trend over the last 3 reported periods earnings are showing a decline.
| Earnings per share | % growth (1) | |
|---|---|---|
| 03/2020 | 231% | |
| 03/2021 | -56% | |
| Average over 3 periods+ | 21% | |
(1) % growth is year on year % change in EPS.
Basic earnings per share are earnings from continuing and discontinued operations that are attributable to current equity holders.
Business Insight
Costs to Revenues ratio of 48.2 in 03/2021 has declined from 0 in 03/2019. Operating costs over the period have increased at a faster pace than the Revenues have increased.
Cost to Revenue ratio (2)
Multiple to Revenue
03/2019 0.0x 03/2020 42.6x 03/2021 48.2x Average multiple over 3 periods+ 53.4x
LowHigh
(2) Costs include selling and admin, depreciation, amortisation and other operating costs.
Costs to Revenues ratio of 48.2 in 03/2021 has declined from 0 in 03/2019. Operating costs over the period have increased at a faster pace than the Revenues have increased.
| Cost to Revenue ratio (2) | Multiple to Revenue | |
|---|---|---|
| 03/2019 | 0.0x | |
| 03/2020 | 42.6x | |
| 03/2021 | 48.2x | |
| Average multiple over 3 periods+ | 53.4x | |
(2) Costs include selling and admin, depreciation, amortisation and other operating costs.
Valuation
Financial Metric
Price multiple to metric Relationship strength between metric and share price ± EBITDA -79.8x 
EBIT -42.4x NI -44.1x FCF -128.6x DPS - Assets 4.3x CE 4.4x
| Financial Metric | ||
|---|---|---|
| EBITDA | -79.8x | |
| EBIT | -42.4x | |
| NI | -44.1x | |
| FCF | -128.6x | |
| DPS | - | |
| Assets | 4.3x | |
| CE | 4.4x | |
The Relationship Strength is statistical measure of how close the data is to a line of best-fit line between share price and the metric shown. It is scaled between zero (no relationship) and 5 (strong relationship).
In this case Total Assets has the strongest relationship to share price, with the company's Market Capital value at 4.3x Total Assets.
+ In cases of change in accounting period length, the average is for the last 3 periods. In all cases, it is dependent on published available data and may be for periods shorter than 3 years
± The ‘Strength’ bar shows the strength of the statistical linear relationship of the metrics shown in the chart over the last three periods of data.
Click here to download a glossary of terms.
All data provided by Fregnan.
| Last results date: 31.03.21 | |
|---|---|
| Enterprise Value | £36.34m |
| EV/EBITDA | (79.82) |
| EV/EBIT | (42.40) |
| PE Ratio | (44.05) |
| PEG | 126.53% |
| Dividend Yield | - |
| Free Cash Yield | (0.78)% |
Click here to download a glossary of terms.
All data provided by Fregnan.
| 31.03.19 (£) |
31.03.20 (£) |
31.03.21 (£) |
|
|---|---|---|---|
| Income Statement | |||
| Revenue | - | 42,666 | 17,896 |
| Operating Income (EBIT) | (551,806) | (1,808,646) | (856,991) |
| Net Income | (538,926) | (1,802,791) | (823,241) |
| Balance Sheet | |||
| Cash | 206,841 | 87,734 | 42,271 |
| Total Debt | 116,539 | 45,000 | - |
| Total Liabilities | 610,933 | 184,327 | 271,154 |
| Total Equity | 8,700,555 | 8,752,032 | 8,210,812 |
| Operating Margin | 0.00% | (4,239.08)% | (4,788.73)% |
| EPS - Basic | (0.66)p | (2.19)p | (0.96)p |
| EPS - Growth | 96.09% | 230.75% | (55.86)% |
| Dividend Per Share | - | - | - |
| Average Shares Outstanding | 81.56m | 82.48m | 85.32m |
| ROA | (5.75%) | (19.76%) | (9.45%) |
| ROCE | (6.15%) | (20.73%) | (10.10%) |
| ROE | (6.01%) | (20.66%) | (9.71%) |
Click here to download a glossary of terms.
All data provided by Fregnan.
| 31.03.19 (£) |
31.03.20 (£) |
31.03.21 (£) |
|
|---|---|---|---|
| Revenue | - | 42,666 | 17,896 |
| Cost of Revenue | - | 33,986 | 12,382 |
| Depreciation & Amortisation | 332,512 | 404,027 | 401,722 |
| Gross Profit | (332,512) | (395,347) | (396,208) |
| Other Operating Expenses | 219,294 | 1,413,299 | 460,783 |
| Operating Income (EBIT) | (551,806) | (1,808,646) | (856,991) |
| Net Interest Expense | - | - | - |
| Unusual Expense (incl. Exceptionals) | 288 | 5,738 | - |
| Non-Operating Expense | - | - | 1,288 |
| Profit (pre-tax) | (552,094) | (1,814,384) | (855,703) |
| Taxation | 13,168 | 11,593 | 32,462 |
| Other Expenses and Minortity Interest | - | - | - |
| Net Income | (538,926) | (1,802,791) | (823,241) |
Click here to download a glossary of terms.
All data provided by Fregnan.
| 31.03.19 (£) |
31.03.20 (£) |
31.03.21 (£) |
|
|---|---|---|---|
| Cash from Operations | 101,617 | (1,504,767) | (282,483) |
| Cash from Investing | (4,424) | - | - |
| Cash from Financing | 101,981 | 1,385,660 | 237,020 |
| Other Miscellaneous | - | - | - |
| Net Cash Flow | 199,174 | (119,107) | (45,463) |
Click here to download a glossary of terms.
All data provided by Fregnan.
| 31.03.19 (£) |
31.03.20 (£) |
31.03.21 (£) |
|
|---|---|---|---|
| Current Assets | 216,138 | 250,774 | 198,104 |
| Non-Current Assets | 9,095,350 | 8,685,585 | 8,283,862 |
| Total Assets | 9,311,488 | 8,936,359 | 8,481,966 |
| Current Liabilities | 610,933 | 184,327 | 271,154 |
| Non-Current Liabilities | - | - | - |
| Total Liabilities | 610,933 | 184,327 | 271,154 |
| Net Assets | 8,700,555 | 8,752,032 | 8,210,812 |
| Total Equity | 8,700,555 | 8,752,032 | 8,210,812 |
Click here to download a glossary of terms.
All data provided by Fregnan.
Address
Business Address
SulNOx Group Plc , 10 Orange Street, Haymarket, London, WC2H 7DQ, United Kingdom.
Email: tony.granger@sulnoxgroupplc.com
Phone: +44 203 291 3638
Registered Address
10 Orange Street, Haymarket, London, WC2H 7DQ, United Kingdom.
Contacts
Corporate Adviser
Allenby Capital Limited., 5 St Helen's Place, London, United Kingdom.
Email: info@allenbycapital.com
Phone: 020 3328 5656
Registrar
Share Registrars Ltd, The Courtyard, 17 West Street, Farnham, Surrey, GU9 7DR, United Kingdom.
Email: enquiries@shareregistrars.uk.com
Phone: 01252 821390
Research
There is no research available.